Market Overview

Intuitive Surgical Well-Positioned For Shift To Robotic Procedures, Piper Jaffray Says In Upgrade

Share:
Intuitive Surgical Well-Positioned For Shift To Robotic Procedures, Piper Jaffray Says In Upgrade
Related ISRG
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs
10 Biggest Price Target Changes For Thursday
Top-Rated Tech, Finance Stocks To Report: Investing Action Plan (Investor's Business Daily)

Robotic surgery device manufacturer Intuitive Surgical, Inc. (NASDAQ: ISRG) reports third-quarter earnings Oct. 18. Piper Jaffray outlined the results of a physician survey in an upgrade note issued ahead of the print. 

The Analyst

Analyst JP McKim upgraded Intuitive Surgical from Neutral to Overweight and raised the price target from $540 to $600.

The Thesis

Procedures such as general surgery and bariatric surgery will likely be completely different in the next five years — and Intuitive Surgical is best-positioned for the shift to robotic surgery, McKim said in the upgrade note. (See the analyst's track record here.) 

Piper Jaffray surveyed doctors practicing in specialties such as oncology, endocrinology, ophthalmology and cardiology on the adoption of robotic surgery.

“Both the physicians and moreso their patients view robotic surgery as better than traditional approaches. They expect robotic surgery in 10 years to penetrate half of the inpatient surgical procedures in the United States," the analyst said.

The doctors see bariatric, thyroid, gallbladder, colon, small bowel, hernia, and lung as being top applications for robotic procedures, with limited interest in pharynx, liver, heart, stomach and brain, McKim said. 

Intuitive Surgical's product upgrades this year have been strong and may demonstrate the early stages of an upgrade cycle, McKim said.

“Strategically, getting as many customers to the fourth-generation systems is prudent ahead of additional competition likely coming in 2020 from the larger players.”

Price Action

Intuitive Surgical shares were down 2.58 percent at $517.51 at the time of publication Wednesday. 

Related Links:

Analyst: Intuitive Surgical Is Moving Into Its 'Most Catalyst Rich' Cycle Ever

Intuitive Surgical Makes New All-Time High After Q3 Beat

Latest Ratings for ISRG

DateFirmActionFromTo
Oct 2018Morgan StanleyMaintainsOverweightOverweight
Oct 2018PiperJaffrayUpgradesNeutralOverweight
Oct 2018PiperJaffrayUpgradesNeutralOverweight

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: JP McKim Piper JaffrayAnalyst Color Upgrades Health Care Price Target Analyst Ratings General Best of Benzinga

 

Related Articles (ISRG)

View Comments and Join the Discussion!
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Why We Prefer Using Cash Over Credit For Small Purchases

Maxim Has An Appetite For Potbelly